Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

NCT03858855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 248

Last updated 2020-08-04

No results posted yet for this study

Summary

This single-blind, randomized controlled trial studies how well inhaled essential oils work for common quality of life concerns in patients who are undergoing cancer treatment such as chemotherapy, targeted therapy, and/or immunotherapy given through the vein (intravenously). Aromatherapy using essential oils, such as ginger essential oil, German chamomile essential oil, and bergamot essential oil, may improve quality of life issues such as nausea, anxiety, loss of appetite, and fatigue in patients undergoing treatment for cancer.

Conditions

Interventions

PROCEDURE

Aromatherapy and Essential Oils

Use bergamot essential oil

PROCEDURE

Aromatherapy and Essential Oils

Use chamomile essential oil

PROCEDURE

Aromatherapy and Essential Oils

Use ginger essential oil

PROCEDURE

Aromatherapy and Essential Oils

Use almond essential oil

OTHER

Subject Diary

Complete journal

Sponsors & Collaborators

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Amber Williams, MSN, RN, OCN · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-18
Primary Completion
2020-04-13
Completion
2020-04-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03858855 on ClinicalTrials.gov